OTCMEMED
Market cap256kUSD
Dec 26, Last price
0.00USD
1D
-25.00%
1Q
-45.45%
IPO
-99.97%
Name
Electromedical Technologies Inc
Chart & Performance
Profile
Electromedical Technologies, Inc., a bioelectronics manufacturing and marketing company, provides medical devices for pain management in the United States. It offers WellnessPro Plus, a bioelectronics therapy prescription device that is used by consumers and health care professionals to relieve chronic and acute pain. The company was founded in 2002 and is headquartered in Scottsdale, Arizona.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
Income | |||||||
Revenues | 1,349 17.30% | 1,150 26.72% | 907 22.96% | ||||
Cost of revenue | 2,978 | 2,509 | 4,543 | ||||
Unusual Expense (Income) | |||||||
NOPBT | (1,629) | (1,359) | (3,636) | ||||
NOPBT Margin | |||||||
Operating Taxes | 1,182 | 3,313 | |||||
Tax Rate | |||||||
NOPAT | (1,629) | (2,541) | (6,949) | ||||
Net income | (2,641) -43.20% | (4,650) -60.57% | (11,794) 154.48% | ||||
Dividends | |||||||
Dividend yield | |||||||
Proceeds from repurchase of equity | 43 | ||||||
BB yield | |||||||
Debt | |||||||
Debt current | 1,442 | 1,337 | 899 | ||||
Long-term debt | 411 | 640 | 673 | ||||
Deferred revenue | |||||||
Other long-term liabilities | 8 | 10 | 9 | ||||
Net debt | 1,766 | 1,608 | 1,189 | ||||
Cash flow | |||||||
Cash from operating activities | (1,417) | (773) | (1,194) | ||||
CAPEX | (150) | ||||||
Cash from investing activities | 1,745 | ||||||
Cash from financing activities | (608) | 759 | 1,312 | ||||
FCF | (697) | (1,579) | (7,629) | ||||
Balance | |||||||
Cash | 88 | 368 | 383 | ||||
Long term investments | |||||||
Excess cash | 20 | 311 | 338 | ||||
Stockholders' equity | (26,700) | (24,458) | (21,527) | ||||
Invested Capital | 25,534 | 24,224 | 22,386 | ||||
ROIC | |||||||
ROCE | 139.73% | 580.30% | |||||
EV | |||||||
Common stock shares outstanding | 377,216 | 133,596 | 50,992 | ||||
Price | |||||||
Market cap | |||||||
EV | |||||||
EBITDA | (1,603) | (1,337) | (3,614) | ||||
EV/EBITDA | |||||||
Interest | 893 | 791 | 3,314 | ||||
Interest/NOPBT |